Polymeric Actuator for Low-Profile Medication Delivery

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Conventional actuators are bulky and uncomfortable for patients, limiting their ability to deliver large volumes of medication efficiently and accurately, especially for high potency medications, and lack a separator material to isolate ionic or pH boundaries, affecting response accuracy and range.

Innovation Solution

A low-profile polymeric actuator assembly with a porous electrode separator material that changes volume in response to pH changes in an electrolyte, powered by a controlled charge input, to displace a collapsible reservoir for precise and efficient fluid delivery.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Force

If conventional actuators are used to deliver medication, then the actuator can generate sufficient force, but the actuator becomes bulky and uncomfortable for patients

Engineering Contradiction:
Improveactuator forceVSAvoidactuator volume
Core Design Contradiction:
ForceVSVolume of moving object

Solution Approach 1:

The patent replaces conventional mechanical actuators (motors, hydraulic cylinders) with a polymeric actuator that responds to pH changes in an electrolyte. This chemical-to-mechanical transduction eliminates bulky mechanical components while maintaining actuation capability, directly resolving the contradiction between force generation and compact size.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent changes the operating parameter from electrical/mechanical control to pH/electrolyte concentration control. By manipulating the pH of the electrolyte, the polymeric actuator changes its volume and generates force, enabling compact actuation without sacrificing performance.

Inventive Principle:
Principle #35Parameter changes

2Reliability

If conventional actuators are used, then the actuator can operate reliably, but the actuator lacks a separator material to isolate ionic or pH boundaries, affecting response accuracy

Engineering Contradiction:
Improveactuator reliabilityVSAvoidpH boundary isolation
Core Design Contradiction:
ReliabilityVSMeasurement precision

Solution Approach 1:

The patent introduces a porous separator material as an intermediary component between the electrolyte and the polymeric actuator. This separator isolates ionic or pH boundaries, ensuring that pH changes are localized and controlled, thereby improving both the reliability of actuation and the precision of the response.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent employs a porous separator material that allows selective ion transport while maintaining pH boundary isolation. The porous structure enables ionic conductivity necessary for actuator operation while preventing uncontrolled pH diffusion, simultaneously achieving reliability and measurement precision.

Inventive Principle:
Principle #31Porous materials

3Quantity of substance

If conventional actuators are used, then the actuator can deliver medication, but the actuator cannot deliver large volumes of medication efficiently and accurately

Engineering Contradiction:
Improvemedication volumeVSAvoidmedication delivery efficiency
Core Design Contradiction:
Quantity of substanceVSProductivity

Solution Approach 1:

The patent employs a collapsible reservoir that dynamically changes shape as medication is delivered. The reservoir collapses inward as fluid is expelled, maintaining efficient contact with the polymeric actuator throughout the delivery process. This dynamic design enables accurate delivery of large volumes without sacrificing efficiency.

Inventive Principle:
Principle #15Dynamics

Solution Approach 2:

The patent segments the medication delivery system into distinct functional components: a collapsible reservoir for volume storage, a porous separator for controlled release, and a polymeric actuator for actuation. This segmentation allows each component to optimize its function, enabling efficient and accurate delivery of large medication volumes.

Inventive Principle:
Principle #1Segmentation

4Volume of moving object

If a low-profile actuator is designed, then the device becomes compact, but the actuator may lack the power to displace large reservoirs

Engineering Contradiction:
Improveactuator sizeVSAvoidactuator power
Core Design Contradiction:
Volume of moving objectVSPower

Solution Approach 1:

The patent uses the electrolyte as a hydraulic medium to transmit force from the polymeric actuator to the collapsible reservoir. The incompressible nature of the electrolyte allows efficient force transmission, enabling a compact actuator to generate sufficient power to displace large volumes of medication through hydraulic amplification.

Inventive Principle:
Principle #29Pneumatics and hydraulics

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The solution enables a compact, efficient, and accurate medication delivery system that improves comfort and increases the volume of medication that can be administered, while ensuring precise control over medication dosage and reducing the risk of errors or delays in pain therapy.

Implementation Method 1

a polymeric actuator configured to generate a large linear displacement over an area in response to a change in an ionic concentration or pH of an electrolyte

Methodology Applied
Scientific EffectpH-responsive volume change: Electroactive Polymer

Implementation Method 2

the state of the art polymer actuators do not include a separator material to isolate and create distinct ionic or pH boundaries of the electrolyte at the anode or cathode side of the electrodes

Methodology Applied
Scientific EffectIonic separation: Semipermeable Membrane

Data Source

PatentUS9238102B2Low profile actuator and improved method of caregiver controlled administration of therapeutics
Publication Date: 2016.01.19 MEDIPACS INC
  • US9238102B2 patent drawing
  • US9238102B2 patent drawing
  • US9238102B2 patent drawing

AI summary

A polymer actuator, power supply and method of using the activation are described.